Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
15.11
-0.39 (-2.52%)
At close: Mar 28, 2025, 4:00 PM
15.00
-0.11 (-0.73%)
Pre-market: Mar 31, 2025, 9:07 AM EDT
Anika Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 55.63 | 68.74 | 86.33 | 94.39 | 95.82 | Upgrade
|
Short-Term Investments | - | - | - | - | 2.5 | Upgrade
|
Cash & Short-Term Investments | 55.63 | 68.74 | 86.33 | 94.39 | 98.32 | Upgrade
|
Cash Growth | -19.07% | -20.37% | -8.54% | -4.00% | -46.84% | Upgrade
|
Receivables | 23.59 | 26.36 | 34.63 | 29.84 | 24.1 | Upgrade
|
Inventory | 23.81 | 24.43 | 39.77 | 36.01 | 46.21 | Upgrade
|
Prepaid Expenses | 5.49 | 7.48 | 8.83 | 8.29 | 8.75 | Upgrade
|
Other Current Assets | 5.13 | 36.31 | - | - | - | Upgrade
|
Total Current Assets | 113.65 | 163.31 | 169.55 | 168.53 | 177.38 | Upgrade
|
Property, Plant & Equipment | 64.68 | 65 | 78.98 | 68.56 | 73.23 | Upgrade
|
Goodwill | 7.13 | 7.57 | 7.34 | 7.78 | 8.41 | Upgrade
|
Other Intangible Assets | 2.49 | 2.58 | 74.6 | 82.38 | 91.16 | Upgrade
|
Long-Term Deferred Tax Assets | 1.18 | 1.49 | 1.45 | - | - | Upgrade
|
Other Long-Term Assets | 7.68 | 30.69 | 17.22 | 20.29 | 15.42 | Upgrade
|
Total Assets | 202.74 | 270.63 | 349.13 | 347.54 | 365.61 | Upgrade
|
Accounts Payable | 5.62 | 6.19 | 9.07 | 7.63 | 8.98 | Upgrade
|
Accrued Expenses | 11.59 | 11 | 15.96 | 16.13 | 13.21 | Upgrade
|
Current Portion of Leases | 1.92 | 1.83 | 2.07 | 1.71 | 1.59 | Upgrade
|
Current Income Taxes Payable | 0.06 | 1.24 | 0.81 | - | - | Upgrade
|
Other Current Liabilities | 4.12 | 10.8 | - | 4.32 | 13.09 | Upgrade
|
Total Current Liabilities | 23.31 | 31.06 | 27.91 | 29.8 | 36.87 | Upgrade
|
Long-Term Leases | 24.01 | 25.92 | 28.82 | 19.24 | 20.88 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | 6.44 | 10.16 | 11.9 | Upgrade
|
Other Long-Term Liabilities | 1.43 | 1.39 | 0.4 | 1.26 | 23.56 | Upgrade
|
Total Liabilities | 48.75 | 58.37 | 63.57 | 60.45 | 93.21 | Upgrade
|
Common Stock | 0.14 | 0.15 | 0.15 | 0.14 | 0.14 | Upgrade
|
Additional Paid-In Capital | 88.96 | 90.01 | 81.14 | 67.08 | 55.36 | Upgrade
|
Retained Earnings | 71.67 | 128.05 | 210.72 | 225.58 | 221.44 | Upgrade
|
Comprehensive Income & Other | -6.78 | -5.94 | -6.44 | -5.72 | -4.54 | Upgrade
|
Shareholders' Equity | 153.99 | 212.27 | 285.56 | 287.09 | 272.4 | Upgrade
|
Total Liabilities & Equity | 202.74 | 270.63 | 349.13 | 347.54 | 365.61 | Upgrade
|
Total Debt | 25.93 | 27.74 | 30.89 | 20.95 | 22.46 | Upgrade
|
Net Cash (Debt) | 29.7 | 41 | 55.44 | 73.43 | 75.85 | Upgrade
|
Net Cash Growth | -27.57% | -26.05% | -24.51% | -3.19% | -53.30% | Upgrade
|
Net Cash Per Share | 2.02 | 2.80 | 3.81 | 5.02 | 5.33 | Upgrade
|
Filing Date Shares Outstanding | 14.18 | 14.66 | 14.63 | 14.47 | 14.33 | Upgrade
|
Total Common Shares Outstanding | 14.42 | 14.66 | 14.63 | 14.44 | 14.33 | Upgrade
|
Working Capital | 90.35 | 132.25 | 141.63 | 138.73 | 140.52 | Upgrade
|
Book Value Per Share | 10.68 | 14.48 | 19.53 | 19.88 | 19.01 | Upgrade
|
Tangible Book Value | 144.37 | 202.12 | 203.63 | 196.92 | 172.83 | Upgrade
|
Tangible Book Value Per Share | 10.01 | 13.79 | 13.92 | 13.64 | 12.06 | Upgrade
|
Machinery | 42.9 | 44.39 | 54.53 | 51.19 | 50.81 | Upgrade
|
Construction In Progress | 6.04 | 2.39 | 5.02 | 1.38 | 0.43 | Upgrade
|
Leasehold Improvements | 36.34 | 34.65 | 34.92 | 34.61 | 34.06 | Upgrade
|
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.